The proteasome inhibitor bortezomib overcomes the inhibition of osteoblast function observed in multiple myeloma

被引：0
|
作者：
Lund, T. [1 ]
Soe, K.
Abilgaard, N. [2 ]
Garnero, P. [3 ]
Pedersen, P. T. [2 ]
Ormstrup, T. E. J.
Delaisse, J.
Plesner, T.
机构：
[1] Vejle Hosp, Dept Clin Cell Biol, Vejle, Denmark
[2] Odense Univ Hosp, DK-5000 Odense, Denmark
[3] INSERM, Res Unit, F-69008 Lyon, France
来源：
BONE | 2010年 / 47卷
关键词：
D O I：
10.1016/j.bone.2010.01.262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S304 / S305
页数：2
相关论文
共 50 条
  • [1] SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
    Heynen, Guus J. J. E.
    Baumgartner, Francis
    Heider, Michael
    Patra, Upayan
    Holz, Maximilian
    Braune, Jan
    Kaiser, Melanie
    Schaeffer, Isabell
    Bamopoulos, Stefanos A.
    Ramberger, Evelyn
    Murgai, Arunima
    Ng, Yuen Lam Dora
    Demel, Uta Margareta
    Laue, Dominik
    Liebig, Sven
    Krueger, Josefine
    Janz, Martin
    Nogai, Axel
    Schick, Markus
    Mertins, Philipp
    Mueller, Stefan
    Bassermann, Florian
    Kroenke, Jan
    Keller, Ulrich
    Wirth, Matthias
    [J]. BLOOD ADVANCES, 2023, 7 (04) : 469 - 481
  • [2] The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients
    Giuliani, Nicola
    Morandi, Francesca
    Tagliaferri, Sara
    Lazzareffi, Mirca
    Bonomini, Sabrina
    Crugnola, Monica
    Mancini, Cristina
    Martella, Eugenia
    Ferrari, Luca
    Tabilio, Antonio
    Rizzoli, Vittorio
    [J]. BLOOD, 2007, 110 (01) : 334 - 338
  • [3] A review of the proteasome inhibitor bortezomib in multiple myeloma
    Richardson, PG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1321 - 1331
  • [4] Proteasome inhibitor bortezomib for the treatment of multiple myeloma
    Cavo, M.
    [J]. LEUKEMIA, 2006, 20 (08) : 1341 - 1352
  • [5] Proteasome inhibitor bortezomib for the treatment of multiple myeloma
    M Cavo
    [J]. Leukemia, 2006, 20 : 1341 - 1352
  • [6] Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
    M Kraus
    J Bader
    H Overkleeft
    C Driessen
    [J]. Blood Cancer Journal, 2013, 3 : e103 - e103
  • [7] Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
    Kraus, M.
    Bader, J.
    Overkleeft, H.
    Driessen, C.
    [J]. BLOOD CANCER JOURNAL, 2013, 3 : e103 - e103
  • [8] Bortezomib - first proteasome inhibitor for the treatment of multiple Myeloma
    Jurczyszyn, Artur
    Skotnicki, Aleksander B.
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (03): : 112 - 124
  • [9] Targeting Redox Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma
    Dolloff, Nathan G.
    Reyes, Leticia
    Smith, Brittany
    Langenheim, John Fairbanks
    Manevich, Yefim
    [J]. BLOOD, 2015, 126 (23)
  • [10] Proteasome inhibitor, bortezomib, for myeloma and lymphoma
    Tobinai, Kensei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (05) : 318 - 326
12345